Arnon P Kater

55PUBLICATIONS
230CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMolecular targetsHaematological tumoursOrganised crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jun 25, 2026
Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies.

|Jun 15, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation.

|Apr 20, 2026
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma.

|Mar 30, 2026
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial.

Moritz Fürstenau, Carsten Utoft Niemann, Sandra Robrecht

|Feb 25, 2026
Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Lars Holger Ehlers, Mark-David Levin, Marjolein van der Klift

|Nov 14, 2025
Tumor-associated disruption of T cell receptor signaling: lessons across cancers with implications for CLL.

Carlota Lopez-Sanchez, Jaco A C van Bruggen, Arnon P Kater

Pageof 10

Frequent Collaborators

11 joint publications

Eric Eldering

11 joint publications

Carsten Utoft Niemann

10 joint publications

Mark-David Levin

9 joint publications

John F Seymour